Quality control for a large-scale study using protein arrays and protein beads to measure immune response in serum and plasma

Proteomics

Volumn 12, Issue 18, 2012, Pages 2802-2807

  Ghevaria, Neha ^a   Visser, Matthieu ^a   Hoffmann, Ralf ^a  

^a PHILIPS RESEARCH LABORATORIES   (Netherlands)

Author keywords

Antibody microarrays; Plasma; Prostate; Protein arrays

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; NANOBEAD;

AMINO ACID SEQUENCE; ARTICLE; BLOOD ANALYSIS; COMPUTER PROGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MEASUREMENT; PLASMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN MICROARRAY; QUALITY CONTROL; REPRODUCIBILITY; SERUM; SIGNAL TRANSDUCTION;

ANTIBODY FORMATION; BLOOD PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; PLASMA; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; QUALITY CONTROL; SERUM;

EID: 84866163940     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200082     Document Type: Article

References (17)

1. + lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma. The Prostate 2008, 68, 1-10.
2. + lymphocyte clusters. Eur. J. Cancer 2009, 45, 1664-1672.
3. Boasberg, P., Hamid, O., O'Day, S., Ipilimumab: unleashing the power of the immune system through CTLA-4 blockade. Semin. Oncol. 2010, 37, 440-449.
4. Cheever, M. A., Higano, C. S., PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. Clin. Cancer Res. 2011, 17, 3520-3526.
5. Buonerba, C., Ferro, M., Di Lorenzo, G., Sipuleucel-T for prostate cancer: the immunotherapy era has commenced. Expert Rev. Anticancer Ther. 2010, 11, 25-28.
6. Xie, C., Kim, H., Haw, J., Kalbasi, A. et al., A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases. J. Transl. Med. 2011, 9, 43.
7. Schweitzer, B., Meng, L., Mattoon, D., Rai A. J., Immune response biomarker profiling application on ProtoArray protein microarrays. Methods in Molecular Biology, 2010, 641, 243-252.
8. Auger, I., Balandraud, N., Rak, J., Lambert, N. et al., New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA. Ann. Rheum. Dis. 2009, 68, 591-594.
9. Hudson, M. E., Pozdnyakova, I., Haines, K., Mor, G., Snyder, M., Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc. Natl. Acad. Sci. 2007, 104, 17494-17499.
10. Gnjatic, S., Wheeler, C., Ebner, M., Ritter, E. et al., Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays. J. Immunol. Meth. 2008, 341, 50-58.
11. Donovan, J., Hamdy, F., Neal, D., Peters, T. et al., Prostate testing for cancer and treatment (ProtecT) feasibility study. Health Technol. Assessment 2003, 7, 1-88.
12. Schröder, F. H., Bangma, C. H., The European Randomized Study of Screening for Prostate Cancer (ERSPC). Br. J. Urol. 1997, 79, 68-71.
13. Team, R. D. C., R Foundation for Statistical Computing, Vienna, Austria 2011.
14. Sboner, A., Karpikov, A., Chen, G., Smith, M. et al., Robust-linear-model normalization to reduce technical variability in functional protein microarrays. J. Proteome Res. 2009, 8, 5451-5464.
15. Lubomirski, M. D. A., Michael, R., Belkowski, S. M., Cabrera, J., Dixon, J. M., Amaratunga, D., A consolidated approach to analyzing data from high-throughput protein microarrays with an application to immune response profiling in humans. J. Comp. Biol. 2007, 14, 350-359.
16. Smith, T. F., Waterman, M. S., Identification of common molecular subsequences. J. Mol. Biol. 1981, 147, 195-197.
17. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat. Biotechnol. 2010, 28, 827-838.